Considering the impact of concurrent Topo IIα and Her-2/neu overexpression on tumour chemosensitivity described in the literature, the association of these two proteins was analysed in relation to tumour regression, but no significant correlation was found either by univariate or multivariate analysis. Here, ERBB2 is linked to neoplasm.